Description
Focusin (Tamsulosin) Capsules with Modified Release 0.4 mg. №90
Ingredients
Active ingredient: Tamsulosin hydrochloride 0.4 mg.
Other ingredients: Lactose monohydrate, methacrylic acid-ethyl acrylate copolymer, microcrystalline cellulose, etc.
Mechanism of Action
Tamsulosin, the active ingredient in Focusin capsules, is a selective alpha-1 adrenergic receptor antagonist. It works by relaxing the muscles in the prostate and bladder neck, thereby improving urine flow and reducing symptoms of benign prostatic hyperplasia (BPH).
Pharmacological Properties
Focusin capsules contain tamsulosin hydrochloride, which exerts its therapeutic effects by blocking alpha-1 adrenergic receptors in the prostate and bladder neck muscles. This action leads to decreased resistance in the urinary tract and improved urine flow.
Indications for Use
Focusin capsules are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH). They help alleviate lower urinary tract symptoms associated with BPH, such as urinary frequency, urgency, weak stream, and incomplete emptying of the bladder.
Contraindications
Do not use Focusin capsules if you are allergic to tamsulosin or any other ingredients in the product. Consult your healthcare provider before starting treatment, especially if you have a history of severe allergic reactions.
Side Effects
Common side effects of Focusin capsules may include dizziness, headache, abnormal ejaculation, rhinitis, and asthenia. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Usage Instructions
Take one Focusin capsule daily, swallowed whole with a glass of water, preferably after the same meal each day. Do not crush, chew, or open the capsules, as they are designed for modified release.
Benefits Compared to Analogues
Focusin capsules offer the advantage of once-daily dosing, providing a convenient treatment option for individuals with BPH. The modified-release formulation ensures a consistent drug concentration in the body, enhancing therapeutic efficacy.
Suitable Patient Groups
Focusin capsules with modified release 0.4 mg are suitable for adult male patients with benign prostatic hyperplasia. They should be used with caution in individuals with severe kidney or liver impairment, requiring close monitoring during treatment.
Storage Conditions and Shelf Life
Store Focusin capsules in a cool, dry place away from direct sunlight. Keep them out of reach of children. Check the expiration date on the packaging and do not use the product after it has expired.
Packaging Description
Focusin capsules are available in a package containing 90 capsules of 0.4 mg each. The packaging is designed to maintain the integrity and stability of the capsules until they are consumed.
Scientific Evidence
Tamsulosin has been extensively studied in clinical trials, demonstrating its efficacy in relieving lower urinary tract symptoms associated with benign prostatic hyperplasia. The selective alpha-1 adrenergic receptor blockade by tamsulosin leads to improved urinary flow and symptom relief in patients with BPH.
